Crit-Line
Payments companies reported to CMS as associated with Crit-Line. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Crit-Line, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Crit-Line
These are the largest totals companies reported as associated with Crit-Line. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Stuart Goldstein | Cincinnati, OH | Pediatric Nephrology | $7,830.08 |
| James Mccabe | Wilmington, NC | Nephrology (Internal Medicine) | $3,250.00 |
| Biruh Workeneh | Houston, TX | Nephrology (Internal Medicine) | $122.13 |
| Sreedhar Mandayam | Houston, TX | Nephrology (Internal Medicine) | $122.12 |
| Navid Saigal | Live Oak, TX | Nephrology (Internal Medicine) | $117.42 |
| Rajesh Mohandas | New Orleans, LA | Nephrology (Internal Medicine) | $107.63 |
| Pradip Chowdhury | Montebello, CA | Nephrology (Internal Medicine) | $107.06 |
| Farshid Yazdi | New Orleans, LA | Nephrology (Internal Medicine) | $106.52 |
| Brad Carter | Oklahoma City, OK | Nephrology (Internal Medicine) | $103.86 |
| James Henry | Fort Smith, AR | Nephrology (Internal Medicine) | $98.34 |
Prescribed Crit-Line?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.